Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

Every year, on October 1st, is World Urticaria Day, a day dedicated to raising awareness about urticaria, commonly known as ...

Celldex Therapeutics reported that its medicine for a condition that causes chronic hives reduced hive activity and, notably, ...

Lusty lads looking to lock lips with Caroline Cray Quinn better be careful because a smooch could prove fatal. The ...

A little over a year ago, I woke up in the middle of the night with an itchy scalp. I didn’t give it much thought, assuming ...

The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

Urticaria may be acute or chronic. As opposed to acute urticaria, chronic urticaria is defined by recurrent episodes occurring at least twice a week for 6 weeks (Grattan, Sabroe, & Greaves ...

Celldex Therapeutics has unveiled 52-week results from a mid-stage study of its anti-KIT drug in chronic hives, raising ...

(RTTNews) - Celldex Therapeutics, Inc. (CLDX), Wednesday announced results from phase 2 study of barzolvolimab for treatment of chronic spontaneous urticaria, an immune-related condition. At the end ...

(150 mg Q4W) achieved complete response at Week 52 -- Rapid, profound and durable improvement in UAS7 as early as Week 1 with a ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...